S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

AQST Aquestive Therapeutics Inc

3.689

0.049 (1.35%)

Dec 20 2024 - Closed

Delayed by 15 minutes

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

null

Aquestive Therapeutics (NASDAQ:AQST)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Aquestive Therapeutics Charts.

Aquestive Therapeutics (NASDAQ:AQST)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Aquestive Therapeutics Charts.

Aquestive Therapeutics Inc News

Form 8-K - Current report
Thursday 19 December 2024 (2 days ago) • Edgar (US Regulatory)

Aquestive Therapeutics Receives U.S. FDA Orphan Drug Exclusivity for Libervant® (diazepam) Buccal Film in Pediatric Patients with Seizure Clusters Ages Two to Five
Thursday 19 December 2024 (2 days ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 2 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Aquestive Therapeutics Announces Positive FDA Feedback and Reaffirms NDA Submission Guidance for Anaphylm™ (epinephrine) Sublingual Film
Monday 2 December 2024 (3 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 27 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences
Tuesday 12 November 2024 (1 month ago) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 8 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 7 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 6 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 4 November 2024 (2 months ago) • Edgar (US Regulatory)

Aquestive Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Monday 4 November 2024 (2 months ago) • GlobeNewswire Inc.

More Aquestive Therapeutics Inc News Articles

Impact Fusion (PK)

CyberFuels (PK)

GBT Technologies (PK)

KULR Technology

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions